Award
NIH Reporter #1R01AI203549-01
LANCET-HBV: Hepatitis B Infection in the Era of Long-Acting ART
Recipient
University of California Los Angeles
Award Amount
$673,177.00
Ceiling
$673,177.00
Awarded
August 04, 2026
Identifier
1R01AI203549-01
Research project awarded to study hepatitis B infection and monitoring in the context of long-acting HIV therapy, funded for approximately $673,177 over five years.
Description
This project involves research on hepatitis B reactivation and monitoring strategies in the context of long-acting HIV therapy, leveraging clinical trials and behavioral studies.